These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1487241

  • 1. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS, King RA.
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [Abstract] [Full Text] [Related]

  • 2. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA, Oetting WS.
    Pigment Cell Res; 1992 Nov; Suppl 2():249-53. PubMed ID: 1409426
    [Abstract] [Full Text] [Related]

  • 3. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA, Mentink MM, Oetting WS.
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [Abstract] [Full Text] [Related]

  • 4. Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism.
    Oetting WS, King RA.
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):274-8. PubMed ID: 1292009
    [Abstract] [Full Text] [Related]

  • 5. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
    Oetting WS, Fryer JP, King RA.
    Hum Mutat; 1998 Nov; 12(6):433-4. PubMed ID: 10671066
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E, Miyamura Y, Matsunaga J, Kano Y, Dakeishi-Hara M, Tanita M, Kono M, Tomita Y.
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [Abstract] [Full Text] [Related]

  • 10. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y, Kato S, Matsunaga J, Aozaki R, Tomita Y, Nishikawa T, Shimizu H.
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [Abstract] [Full Text] [Related]

  • 11. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE, Zhao H, Oetting WS, Austin LM, Wildenberg SC, Boissy YL, Zhao Y, Sturm RA, Hearing VJ, King RA, Nordlund JJ.
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS, King RA.
    Hum Mutat; 1993 Jun; 2(1):1-6. PubMed ID: 8477259
    [Abstract] [Full Text] [Related]

  • 13. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S.
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tyrosinase gene mutations causing oculocutaneous albinisms.
    Tomita Y.
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):186S-190S. PubMed ID: 8433007
    [Abstract] [Full Text] [Related]

  • 16. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS, Handoko HY, Mentink MM, Paller AS, White JG, King RA.
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.